Digital Health

A woman in a lab coat standing in front of a green background with Hims Hers branded products floating around her
Favicon Fierce Healthcare

Hims & Hers plans to launch $49 copy of Wegovy pill

Novo Nordisk is threatening legal and regulatory action against Hims & Hers for its "unapproved, inauthentic, and untested knockoff semaglutide pill."
Heather Landi Feb 5, 2026 1:00pm
Wegovy
Favicon Fierce Healthcare

Hims & Hers stock drops 30% after Novo Nordisk terminates deal

Jun 23, 2025 12:00pm